Arcalyst

Product NDC
73604-914
11-digit product format
736040914
Labeler code
73604
Product ID
73604-914_11e22c54-9b9a-4f9f-8680-cb7327511a23
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
rilonacept
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Labeler
Kiniksa Pharmaceuticals (UK), Ltd.
Application
BLA125249
Marketing category
BLA
Marketing start
2008-02-27
Substance
RILONACEPT
Active strength
160 mg/2mL
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Arcalyst
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RILONACEPT160 mg/2mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii8K80YB5GMG
Rxcui763453, 763457

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
82859377-bb37-4b99-bc88-4c78558a1c99Product name120210916
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
1681bc73-b05f-12c3-1075-382ae39f449cProduct name120140508
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73604-914-01Arcalyst2 mL in 1 VIAL, SINGLE-USEINJECTION, POWDER, LYOPHILIZED,216
73604-914-01Arcalyst1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,116
73604-914-04Arcalyst2 mL in 1 VIAL, SINGLE-USEINJECTION, POWDER, LYOPHILIZED,216
73604-914-04Arcalyst4 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,416

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73604-914ARCALYST (RILONACEPT) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [KINIKSA PHARMACEUTICALS (UK), LTD.]13Current NDC, Legacy NDC, 4 package rows20250313_ad965f38-dd22-4607-a673-2fb92f3b527a.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
763457Arcalyst 220 MG InjectionPSNad965f38-dd22-4607-a673-2fb92f3b527a16
763453rilonacept 220 MG InjectionPSNad965f38-dd22-4607-a673-2fb92f3b527a16
763457rilonacept 220 MG Injection [Arcalyst]SBDad965f38-dd22-4607-a673-2fb92f3b527a16
763453rilonacept 220 MG InjectionSCDad965f38-dd22-4607-a673-2fb92f3b527a16
763457Arcalyst 220 MG InjectionSYad965f38-dd22-4607-a673-2fb92f3b527a16

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
73604-914-01736040914011 VIAL, SINGLE-USE in 1 CARTON (73604-914-01) / 2 mL in 1 VIAL, SINGLE-USE2021-06-180000-00-00NoNoCurrent
73604-914-04736040914044 VIAL, SINGLE-USE in 1 CARTON (73604-914-04) / 2 mL in 1 VIAL, SINGLE-USE2008-03-240000-00-00NoNoCurrent